Mirum Pharmaceuticals, Inc. (MIRM) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$521.3M

Net Income/Loss (FY2025)

-$23.4M

Total Assets (FY2025)

$842.8M

Total Equity (FY2025)

$314.7M

Cash Flows from Operating Activities (FY2025)

$55.8M

Source: Mirum Pharmaceuticals, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.